These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25438813)

  • 21. Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets.
    Johung TB; Monje M
    Curr Neuropharmacol; 2017; 15(1):88-97. PubMed ID: 27157264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.
    Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS
    Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
    Deweyert A; Iredale E; Xu H; Wong E; Schmid S; Hebb MO
    J Neurooncol; 2019 May; 143(1):49-56. PubMed ID: 30852713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse intrinsic pontine glioma: time for therapeutic optimism.
    Khatua S; Zaky W
    CNS Oncol; 2014; 3(5):337-48. PubMed ID: 25363006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of diffuse pontine gliomas in children: recent developments.
    Kebudi R; Cakir FB
    Paediatr Drugs; 2013 Oct; 15(5):351-62. PubMed ID: 23719782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope?
    Cohen KJ; Jabado N; Grill J
    Neuro Oncol; 2017 Aug; 19(8):1025-1034. PubMed ID: 28371920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.
    Aziz-Bose R; Monje M
    Curr Opin Oncol; 2019 Nov; 31(6):522-530. PubMed ID: 31464759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new era for children with diffuse intrinsic pontine glioma: hope for cure?
    Jansen MH; Kaspers GJ
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1109-12. PubMed ID: 23098109
    [No Abstract]   [Full Text] [Related]  

  • 29. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.
    Zarghooni M; Bartels U; Lee E; Buczkowicz P; Morrison A; Huang A; Bouffet E; Hawkins C
    J Clin Oncol; 2010 Mar; 28(8):1337-44. PubMed ID: 20142589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.
    Infinger LK; Stevenson CB
    Curr Neuropharmacol; 2017; 15(1):129-133. PubMed ID: 27109746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options for paediatric brainstem gliomas.
    Khan DA; Laghari AA; Bari ME; Shamim MS
    J Pak Med Assoc; 2019 Sep; 69(9):1400-1402. PubMed ID: 31511736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.
    Ballester LY; Wang Z; Shandilya S; Miettinen M; Burger PC; Eberhart CG; Rodriguez FJ; Raabe E; Nazarian J; Warren K; Quezado MM
    Am J Surg Pathol; 2013 Sep; 37(9):1357-64. PubMed ID: 24076776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
    Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
    Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG.
    Bartels U; Hawkins C; Vézina G; Kun L; Souweidane M; Bouffet E
    J Neurooncol; 2011 Oct; 105(1):119-25. PubMed ID: 21901544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric diffuse intrinsic pontine glioma patients from a single center.
    Kebudi R; Cakir FB; Agaoglu FY; Gorgun O; Ayan I; Darendeliler E
    Childs Nerv Syst; 2013 Apr; 29(4):583-8. PubMed ID: 23224361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma.
    Warren KE
    CNS Oncol; 2014 May; 3(3):181-3. PubMed ID: 25055124
    [No Abstract]   [Full Text] [Related]  

  • 37. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
    Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
    Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic virotherapy for the treatment of pediatric brainstem gliomas.
    Gállego Pérez-Larraya J; García-Moure M; Alonso MM
    Rev Neurol (Paris); 2023 Jun; 179(5):475-480. PubMed ID: 37061388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
    Fangusaro J
    J Child Neurol; 2009 Nov; 24(11):1409-17. PubMed ID: 19638636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival.
    Silva-Evangelista C; Barret E; Ménez V; Merlevede J; Kergrohen T; Saccasyn A; Oberlin E; Puget S; Beccaria K; Grill J; Castel D; Debily MA
    Oncogene; 2019 Sep; 38(38):6479-6490. PubMed ID: 31324890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.